Viva Health policy updates
Track new and updated Viva Health policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Xolair® (omalizumab) — Concomitant Therapy Contraindications and Dosing Guidance | Viva Health | Clinical | Allergy/Clinical Immunology | Modified | Jul 1, 2026 |
| Evenity (romosozumab-aqqg) (Subcutaneous) — Coverage Criteria | Viva Health | Clinical | Endocrinology | Modified | Jul 1, 2026 |
| Short-Acting Granulocyte Colony Stimulating Factors (SA-G-CSF) | Viva Health | Clinical | Hematology/Oncology | Modified | Jul 1, 2026 |
| Tecentriq (atezolizumab) — Coverage and Authorization Policy | Viva Health | Clinical | Hematology/Oncology | Modified | Jul 1, 2026 |
| Golimumab (Immgolis INTRI®, Simponi ARIA®) — Intravenous | Viva Health | Clinical | Immunology/Rheumatology | Modified | Jul 1, 2026 |
| Dysport® (abobotulinumtoxinA) — Coverage Criteria | Viva Health | Clinical | Neurology/Neurosurgery | Modified | Jul 1, 2026 |
| Onpattro (patisiran) intravenous therapy for hATTR polyneuropathy | Viva Health | Clinical | Neurology/Neurosurgery | Modified | Jul 1, 2026 |
| Qalsody (tofersen) (Intrathecal) — Coverage Criteria | Viva Health | Clinical | Neurology/Neurosurgery | Modified | Jul 1, 2026 |
| Radicava (edaravone) — Intravenous | Viva Health | Clinical | Neurology/Neurosurgery | Modified | Jul 1, 2026 |
| Bavencio (avelumab) coverage and authorization | Viva Health | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 1, 2026 |
Rows per page:1–10 of 367
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.